Sonja Johnson, DO
Psychiatry · Lancaster, OHNPI 1053931048
Payments from drug & device makers
Across 190 payments — averaging $15.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$670
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$484
- Otsuka America Pharmaceutical, Inc.$309
- Axsome Therapeutics, Inc.$303
- Alkermes, Inc.$248
- Neurocrine Biosciences, Inc.$171
- plus $721 from 11 others
What the payments were for
- Food & beverage$2,906100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $670 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 43 | $484 |
| Otsuka America Pharmaceutical, Inc. | 18 | $309 |
| Axsome Therapeutics, Inc. | 19 | $303 |
| Alkermes, Inc. | 15 | $248 |
| Neurocrine Biosciences, Inc. | 8 | $171 |
| Supernus Pharmaceuticals, Inc. | 11 | $169 |
| Vanda Pharmaceuticals Inc. | 13 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $107 |
| Sun Pharmaceutical Industries Inc. | 3 | $68 |
| LEO Pharma Inc. | 3 | $50 |
| Collegium Pharmaceutical, Inc. | 2 | $47 |
| Johnson & Johnson | 2 | $38 |
| E.r. Squibb & Sons, L.L.C. | 2 | $35 |
| Corium, LLC | 1 | $23 |
| Lundbeck LLC | 1 | $15 |
| AstraZeneca | 1 | $15 |
How this compares
$2,906 in reported general payments places this provider in the 80th percentile of 1,119 psychiatry providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lamotrigine ErLamotrigine | 13 | $2,614 |
| Duloxetine Hcl | 14 | $741 |
| Guanfacine Hcl ErGuanfacine Hcl | 19 | $296 |
| Quetiapine Fumarate | 14 | $203 |
| Clonazepam | 14 | $70 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Lancaster
- Shishuka MalhotraCanton$15M
- Henry NasrallahCincinnati$3.8M
- Otto DuenoDayton$3.1M
- Diab AlmhanaAvon Lake$2.7M
- Mohamed Abdel AzizWest Chester$2.6M
- Fred RomeoColumbus$2.3M
- Mark WoyshvilleMiddleburg Heights$2.2M
- Amita PatelDayton$2.1M
- Caleb AdlerCincinnati$2M
- Richard SandersDayton$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.